Welcome to Weekly Health Update

New research shows that high blood pressure, high cholesterol, diabetes, and smoking account for the vast majority of all deaths caused by cardiovascular disease.

THE FOUR CRITICAL CARDIOVASCULAR DISEASE RISKS THAT YOU CAN CHANGE

As I mention in my recent bestselling book, A Cancer Prevention Guide for the Human Race, many of the very same lifestyle and dietary habits that increase our risk of developing cancer also increase our risk of developing cardiovascular disease, including coronary artery disease, heart attacks (myocardial infarction), peripheral vascular disease, and stroke.  Likewise, adopting an evidence-based cancer prevention lifestyle can not only cut your cancer risk in half, but can also significantly reduce your risk of developing life-threatening cardiovascular disease as well.

A newly published research study, which was funded by the National Institutes of Health, provides, for the first time, a comprehensive assessment of the lifetime risks of developing cardiovascular disease based upon the following four health-related factors: blood pressure, cholesterol (lipid) levels in the blood, smoking status, and diabetes status.  Importantly, this huge meta-analysis study, which appears in the current issue of the New England Journal of Medicine, comprehensively analyzes the data from 18 different prior clinical research studies, which included 257,384 adult black and white men and women.  These research volunteers were assessed for these four critical cardiovascular risk factors every 10 years, beginning at age 45 and ending at age 75.  This enormous group of research volunteers was then closely followed, and the incidence of cardiovascular disease and death rates due to cardiovascular disease were then carefully evaluated and analyzed.

When looking at cardiovascular risks factors at age 55 as predictors of future cardiovascular disease risk, and the risk of death due to cardiovascular disease, the findings of this extremely large clinical study were striking.  In this study, a low-risk profile for cardiovascular disease was defined as total blood cholesterol less than 180 milligrams per deciliter (4.7 mmol per liter), average blood pressure less than 120/80 millimeters of mercury (mm Hg), nonsmoker status, and nondiabetic status.

Among the 55 year-old men and women who met all of the criteria for a low-risk profile for cardiovascular disease, their lifetime incidence of cardiovascular disease, through age 80, was remarkably lower than for the 55 year-olds who failed to meet two or more of the four low-risk criteria.  In fact, the risk of death due to cardiovascular disease, through age 80, was only 5 percent among the men who met all four low-risk criteria at age 55, while the men who met only two or fewer low-risk criteria faced a dramatic six-fold increase in the risk (30 percent) of dying of cardiovascular disease by age 80.  Among the women volunteers, only 6 percent of the women who met all four low-risk criteria went on to die of cardiovascular disease by age 80, while 21 percent of the women who failed to meet two or more of the four low-risk criteria died of cardiovascular disease between age 55 and age 80 (for a nearly four-fold increase in the risk of death).

Fatal and nonfatal coronary artery disease occurred in only 4 percent of the men who met all four low-risk criteria, but occurred in nearly 10 times as many of the men (38 percent) who failed to meet two or more of these four criteria.  The women who met all four low-risk criteria faced a less than 1 percent risk of fatal and nonfatal coronary artery disease, while the women who met two or fewer low-risk criteria experienced an 18 percent incidence of fatal and nonfatal coronary artery disease (for a more than 18-fold increase in risk).

The risk of fatal and nonfatal stroke was also significantly lower among men and women who met all four low-risk criteria for cardiovascular disease.  Among the men who met all four low-risk criteria, the incidence of stroke through age 80 was only about 2 percent, but quadrupled, to more than 8 percent, among the men who failed to meet two or more of the four low-risk criteria.  Among the women who met all four low-risk criteria, the incidence of stroke was about 5 percent, but more than doubled, to nearly 11 percent, among the women who failed to meet at least two of the low-risk criteria.

The findings of this very large study cannot be overstated in terms of its public health importance, as this is the only study that has prospectively assessed very large numbers of men and women, including both black and white adults, over long periods of time, and that has analyzed the long-term impact of the four most common risk factors for cardiovascular disease on incidence and death rates associated with cardiovascular disease.  As with the studies that I discuss in A Cancer Prevention Guide for the Human Race, the impact of lifestyle, diet, and other modifiable health-related factors on both cardiovascular disease risk and cancer risk is enormous, particularly when measured over the lifespan of the average adult.

The findings of this epic public health research study also add further weight to my strong belief, based upon my review of thousands of research studies, that we, as individuals, hold the key to improving our health, and to significantly reducing our risk of serious illness and premature death, by living evidence-based healthy lifestyles.  If your blood pressure is high, change your diet and increase your level of exercise, with the support of your doctor.  If diet and physical activity interventions alone do not correct your hypertension, then ask your doctor about medications for high blood pressure.  If you have diabetes, you also need to change your diet, increase your levels of physical activity, and safely lose any excess weight.  If these lifestyle changes do not completely resolve your high blood sugars, then you may also need to ask your doctor about medications for diabetes.  If you smoke, or use smokeless tobacco, stop immediately.  Finally, if your LDL and total cholesterol levels are high, then, once again, you need to be more careful about what you eat.  (The cancer-preventing foods and diets that I discuss in my book have also been linked to lower levels of blood cholesterol, as well as a much lower risk of cardiovascular disease.)  You may also need to increase your physical activity levels, and get your weight down to a healthy level, to improve your LDL and total cholesterol levels.  Once again, if these prudent lifestyle measures are not enough, by themselves, to bring your cholesterol levels down into the normal range, then your doctor may need to add a cholesterol-lowering medication as well.

The striking results of this important cardiovascular disease prevention study provide all of us with the key to maximally reducing our risk of developing—and dying from—largely preventable cardiovascular diseases, including heart disease and stroke.  Better long-term health (and a longer and more vigorous life) is within your grasp, and this study, in addition to my book, can show you the way forward.

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million, Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

KIDS, VEGETABLES, DIET, AND REWARDS

My now 10 year-old daughter used to eat almost everything that we put in front of her when she was a toddler.  Lately, however, she has decided that all she wants to eat is macaroni and cheese or mashed potatoes.  My now 7 year-old son, on the other hand, spent the years between age 3 and age 5 subsisting largely on “chicken nuggets” and multi-vitamins, and little else….  (The first time that I was able to persuade him to eat some broccoli, at age 5, after suggesting that he dip this much-maligned vegetable in ranch sauce and grated parmesan cheese, I was moved nearly to tears!)

Most kids are fussy eaters, and getting your child to eat a healthy, balanced diet can be a serious challenge, if not a perpetual struggle between parent and child.  As with most aspects of child-rearing, there are a number of recommended strategies to get Junior to eat his or her vegetables, and other healthy foods.  However, many of these strategies turn out to be utterly ineffective in practice.  Certainly, one of the most commonly recommended strategies is to offer reluctant young eaters various types of rewards for healthy eating (and which is, in my view, tantamount to bribery, but which has probably been resorted to by most of us parents during times of diet-related desperation, and with varying results).  (As I discuss in my bestselling evidence-based book, A Cancer Prevention Guide for the Human Race, fresh vegetables, whole grains, and reduced meat intake have all been associated with a reduced risk of developing both cancer and cardiovascular disease.)

Given the never-ending mealtime struggles in our own home, I came across an interesting new research study related to this very topic, and which appears in the current issue of the American Journal of Clinical Nutrition.  In this innovative little prospective, randomized, controlled clinical study, 173 children, ages 3 to 4 years, were divided into three groups.  All of these children were exposed to vegetables, 12 times per day, that they were known to dislike after these vegetables were first introduced.  The first group of children received a tangible reward (a sticker) each time after being served a vegetable that they had initially disliked.  The second group of children received praise as a reward upon being served vegetables that they too had disliked upon initial presentation.  Finally, a third group (the “control group”) was served vegetables that they had also initially disliked, but this group of children did not receive any rewards (i.e., no stickers and no praise).

The findings of this study, while not terribly surprising, offer parents a potential strategy to improve the diets of their (our) vegetable-hating kids.  Of course, the children who were repeatedly served disliked vegetables, and who received no stickers or praise, continued to refuse repeated servings of these vegetables.  However, the toddlers who were bribed with stickers (a material reward) significantly improved their intake of the offending vegetables over time, and this improvement in vegetable consumption persisted when the children were reevaluated 3 months later.  Importantly, the children in this “material reward” group were also significantly more likely to develop a liking for these same vegetables over time!   The third group of children, who received praise (a “social” reward) along with each serving of undesired vegetables, sadly, and somewhat unexpectedly, were no more likely to increase their consumption of these vegetables over time, or to develop a liking for these vegetables, than the kids who were in the “no reward” control group!

In this clinical study of toddlers, offering children a material reward (stickers, in the case of this clinical study) in conjunction with repeated introductions of initially disliked vegetables resulted in a significant improvement, over time, in the willing consumption of these vegetables, as well as in increased “liking” of these same vegetables.  Positive reinforcement through praise was, however, completely ineffective in getting these little tykes to eat (and like) their veggies.

In the case of my son, “the vegetable-hater,” the Broccoli Breakthrough occurred on an evening when I took him and his sister out for dinner.  In exchange for the privilege of the three of us playing a family card game during our meal, and as a result of my inspired suggestion that he combine two foods that he loved (grated parmesan cheese and ranch dipping sauce) with a food that he hated (the aforementioned broccoli), the miracle of witnessing my little guy downing several florets of broccoli coated in ranch sauce and parmesan cheese finally came to pass.  I was so overcome by that moment, two years ago, as was my daughter, that I remember it like it happened yesterday.  Moreover, knowing that my wife would almost certainly doubt my incredible claim that this event had actually occurred, I documented this miraculous development with my cell phone camera on the spot, and emailed it to her from the restaurant that night.  Nearly two years later, I am happy to report that while both of our kids still challenge us in our ongoing efforts to get them to eat a healthy, balanced diet, our son (and daughter) will still regularly eat that most despised vegetable among children, broccoli!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

MEAT CONSUMPTION AND COLORECTAL CANCER RISK

As I discuss in my bestselling evidence-based book, A Cancer Prevention Guide for the Human Race, our dietary habits have an enormous impact on our risk of developing cancer, and particularly cancers of the gastrointestinal tract.  Colorectal cancer risk, specifically, has been directly linked to diets high in red meat, processed meats, grilled meats, and other animal-based fats.  However, the majority of research data linking these dietary factors to colorectal cancer risk, and the premalignant “adenomatous” polyps that precede the development of colorectal cancer, has been based upon one-time surveys and one-time clinical examinations performed on public health research study volunteers.  Because of the known limitations of such studies, more compelling research data is needed to show, convincingly, that these dietary factors are indeed associated with a greater risk of premalignant and malignant tumors of the colon and rectum.  Now, a newly published research study, which appears in the British Journal of Cancer, provides this higher-level data which, once again, confirms a link between meat-rich diets and colorectal cancer risk.

More than 17,000 volunteers participated in the prospective, giant Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCOCS Trial).  All of these clinically healthy volunteers underwent endoscopic examinations of the rectum and lower colon (proctosigmoidoscopy) both when they entered into the PLCOCS Trial and again during a follow-up examination.  Careful dietary records were also kept by all participants in this very large cancer screening trial.

A total of 1,008 research volunteers were found to have premalignant polyps (adenomas) of the lower colon and rectum during these two separate endoscopic colorectal examinations.  In this huge population of otherwise healthy research volunteers, the frequent consumption of grilled meat was associated with a 56 percent increase in the risk of developing premalignant colorectal adenomas, while increased intake of well- or very-well done cooked meat was associated with a 59 percent increase in the risk of colorectal adenomatous polyps.  Interestingly, despite the fact that the iron pigment in red meat (heme) has long been suspected of acting as a carcinogen within the colon and rectum, total dietary iron intake actually appeared to be somewhat protective against colorectal adenomas in this study; and study participants with higher levels of total iron intake were 31 percent less likely to develop colorectal adenomas.

This study, with its prospective design, its very large number of research participants, and its baseline and follow-up proctosigmoidoscopic exams, provides a more accurate view of the impact of meat intake on the risk of developing precancerous colorectal adenomatous polyps when compared to most previous similar research studies.  The findings of this huge clinical research study, therefore further confirm that precancerous colon and rectal adenomatous polyps are, indeed, strongly associated with meat intake in our diets.

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

SWEET POTATO GREENS AND PROSTATE CANCER

As I discuss in my bestselling evidence-based book, A Cancer Prevention Guide for the Human Race, even conservative clinical research assessments strongly suggest that at least 50 percent of all new cancer cases are linked to modifiable lifestyle and dietary habits.  Polyphenols, a group of powerful dietary antioxidant compounds that I extensively discuss in A Cancer Prevention Guide for the Human Race, have been extensively studied in numerous laboratory and clinical research studies as potential cancer prevention nutrients.  Now, a newly published study suggests that polyphenol-rich sweet potato greens may have significant anticancer activity against prostate cancer

In this new study, which appears in the current issue of the journal Carcinogenesis, an extract of sweet potato greens was first tested in the laboratory with human prostate cancer cells growing in culture.  Molecular studies were then performed, which revealed that sweet potato greens extract shut down important cell growth biochemical pathways in human prostate cancer cells, and accelerated cancer cell death through a mechanism known as apoptosis.  (Interestingly, and importantly, however, sweet potato greens extract appeared to have no adverse effects on normal human prostate gland cells.)

As it is well known that the results of laboratory-based studies often cannot be reproduced in animal or human studies, the authors of this study then implanted human prostate cancer cells into laboratory mice.  These same mice were then fed sweet potato greens extract (400 milligrams per kilogram per day), while another group of mice (the “control group”) did not receive any sweet potato greens extract.  At the end of the study, the scientists conducting this research discovered that the prostate cancer tumors growing in the mice who received the sweet potato greens extract were, on average, almost 70 percent smaller than the tumors growing in the control group mice!  (Once again, there also appeared to be no adverse effects on normal tissues and organs in the mice that received the sweet potato greens extract.)

This research study is the first study to identify significant anticancer effects against prostate cancer associated with sweet potato greens in both cancer cell cultures and in mammals.  The potent anticancer effects of sweet potato greens extract, as demonstrated in this very elegant study, and combined with the apparent lack of toxicity, suggest that this polyphenol-rich vegetable may have a role in prostate cancer prevention and, perhaps, prostate cancer treatment; although it will be necessary to repeat this laboratory study in humans to determine if sweet potato greens have similar anticancer effects in people.

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

DIETARY FIBER AND COLON AND RECTAL CANCER PREVENTION

For many years, it was widely believed that a diet rich in fiber, and rich in fresh fruits and vegetables in particular, significantly reduced the risk of developing colorectal cancer.  However, more recent public health studies have called this assumption into question.  As I extensively discuss in my bestselling book, A Cancer Prevention Guide for the Human Race, there is ample clinical evidence that a so-called Mediterranean diet, which does include large amounts of fresh fruits and vegetables (as well as foods rich in unprocessed whole grains), dramatically reduces the risk of colorectal cancer and other GI tract cancers.  Now, a landmark new meta-analysis research study provides important new evidence that certain high-fiber foods may, indeed, be associated with a significantly reduced risk of colorectal cancer.  This comprehensive research study appears in the current issue of the British Medical Journal.

In this huge meta-analysis, 25 prospectively conducted public health studies, including 14,500 study volunteers, were analyzed; and the findings of this large clinical study may explain why recent large public health studies have not been able to confirm that a diet rich in all types of fiber can reduce colorectal cancer risk.  In this meta-analysis study, dietary fiber from fruit and vegetable intake did not appear to significantly reduce the risk of developing colorectal cancer.  However, whole grain foods, including cereals rich in whole grains, did appear to significantly reduce colorectal cancer risk.  In fact, for each 10 grams of whole grain fiber consumed per day, colorectal cancer risk was reduced by a very significant 10 percent.  Among research volunteers who consumed at least three servings of whole grains each day, the risk of developing colorectal cancer was reduced by 17 percent.

The health implications of this meta-analysis study are highly significant.  First of all, the authors of this study included only prospectively conducted public health studies in their analysis, thus eliminating some of the major limitations associated with the more common retrospective “case control” studies that make up the majority of public health studies on diet and disease prevention.  (As I have often mentioned, retrospective case control and case series studies are very often flawed by “recall bias,” wherein the data that is collected is based purely upon the recollections of volunteers recruited into such studies.)  Secondly, the findings of this meta-analysis are supported by higher level research studies that have found that highly refined grains and cereals are stripped of important cancer-preventing nutrients and bulk fiber during processing.

While fresh fruits and vegetables (and brightly colored and dark green leafy vegetables in particular) have been shown by other studies to reduce overall cancer risk, this landmark meta-analysis study appears to reconcile the contradictory findings of previous cancer prevention studies regarding the impact of dietary fiber intake on, specifically, colorectal cancer risk.  Based upon the findings of this very important study, a diet rich in unprocessed, or minimally, processed, whole grain foods appears to significantly protect against colorectal cancer.  (For a much broader and deeper review of evidence-based approaches to cancer prevention, see my book, A Cancer Prevention Guide for the Human Race.)

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

A large meta-analysis suggests that aspirin may lower a woman’s risk of developing breast cancer.

ASPIRIN MAY HELP TO PREVENT BREAST CANCER

As I have discussed in my bestselling book, A Cancer Prevention Guide for the Human Race, aspirin may have an important potential role in the prevention of certain types of cancer, including colorectal cancer and pancreatic cancer.  However, the available research data on aspirin as a breast cancer prevention medication has been rather mixed, to date.

A new meta-analysis study, which appears in the current issue of the journal Breast Cancer Research & Treatment, adds weight to previous studies suggesting a potential role for aspirin in the prevention of breast cancer.  In this meta-analysis, the results of 33 different clinical research studies were analyzed.  Altogether, nearly two million research volunteers participated in these 33 studies.  When considering the results of these 33 different research studies, the authors of this meta-analysis determined that the regular use of aspirin was associated with an average 14 percent reduction in the risk of developing breast cancer.

While this meta-analysis study showed an overall trend towards a decreased risk of developing breast cancer in women who regularly took aspirin, there is one very important caveat that I must emphasize.  Only one of the 33 research studies that were analyzed in this meta-analysis was a prospective, randomized, placebo-controlled study (i.e., the type of clinical research study that provides the highest level of scientific and clinical findings), and it was this study, alone among the 33 different clinical studies, that did not find any breast cancer prevention benefit associated with regular aspirin use.

While all but one of the 33 clinical research studies in this meta-analysis identified a significant reduction in breast cancer risk in women who regularly took aspirin, the failure of the lone prospective, randomized, placebo-controlled clinical research trial to confirm this finding means that additional prospective, randomized, placebo-controlled research studies will need to be performed before aspirin can be definitively recommended as a breast cancer prevention medication.

As I have stressed before, all medications, including aspirin, can be associated with potentially serious side effects.  Therefore, if you are considering aspirin therapy, for the prevention of heart disease or cancer, then it is very important for you to check with your doctor before you begin taking aspirin.

For a comprehensive guide to living an evidence-based cancer prevention lifestyle, order your copy of my new book, A Cancer Prevention Guide for the Human Race.  For the price of a cheeseburger, fries, and a shake, you can purchase this landmark new book, in both paperback and e-book formats, and begin living an evidence-based cancer prevention lifestyle today!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

A large new public health research study from China suggests that drinking green tea at least 3 times per week may cut colorectal cancer risk in half, but only among nonsmokers.

GREEN TEA MAY PREVENT COLON AND RECTAL CANCER

As I have written about in my bestselling book, A Cancer Prevention Guide for the Human Race, green tea has been consumed for several thousand years now, and the health benefits attributed to this ancient beverage have been numerous. Unfortunately, the published research findings regarding green tea’s claimed health benefits continue to be quite contradictory, including in the area of cancer prevention research.

A newly published public health study from China, which appears in the journal Carcinogenesis, adds to previous studies that have suggested a favorable role for green tea in cancer prevention. In this very large prospective public health study, 60,567 Chinese men (ages 40 to 74 years) were followed for an average of about 5 years. The incidence of new colorectal cancers was assessed in this very large cohort of research volunteers, and the consumption of green tea was assessed as a potential factor in the incidence of colorectal cancer among these men.

In this huge prospective public health study, the regular consumption of green tea (defined as green tea consumption at least 3 times per week, and for more than 6 consecutive months) was associated with a significant decrease in the risk of developing colorectal cancer. However, this observed colorectal cancer prevention benefit was limited to nonsmokers, as green tea consumption appeared to have no beneficial effect on colorectal cancer risk among men who smoked.

Among nonsmoking men, the regular consumption of green tea was associated with a very impressive 46 percent reduction in the risk of developing colorectal cancer. Importantly, higher reported levels of green tea intake were associated with correspondingly greater reductions in colorectal cancer risk (but, once again, only in nonsmokers). This “dose-response” relationship is a very important consideration, because any true cancer prevention effect by green tea should, indeed, exhibit this kind of dose-dependent impact on cancer risk reduction.

While only a large-scale prospective, randomized, double-blinded, placebo-controlled clinical research trial can definitively prove whether or not regular green tea consumption can prevent colorectal cancer, the results of this very large prospective public health study suggest that green tea may indeed have an important role to play in colorectal cancer prevention.

For a comprehensive guide to living an evidence-based cancer prevention lifestyle, order your copy of my new book, A Cancer Prevention Guide for the Human Race.  For the price of a cheeseburger, fries, and a shake, you can purchase this landmark new book, in both paperback and e-book formats, and begin living an evidence-based cancer prevention lifestyle today!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

New research shows that aspirin may significantly reduce the risk of pancreatic cancer, one of the deadliest of all cancers.

ASPIRIN MAY REDUCE THE RISK OF DEADLY PANCREATIC CANCER

The recent tragic death of Steve Jobs, of Apple fame, due to a rare form of pancreatic cancer has once again focused public attention on one of the deadliest forms of cancer. The more common form of pancreatic cancer, pancreatic ductal cancer, is only the tenth most common form of cancer, but because it is such a lethal disease, pancreatic cancer is actually the fourth most common cause of cancer-related death. Sadly, only about 5 percent of people diagnosed with pancreatic cancer will still be alive 5 years later.

In my book, A Cancer Prevention Guide for the Human Race, I extensively discuss the available research findings that can help to lower your risk of pancreatic cancer, and other deadly forms of cancer. (Also, please see my recent report on pancreatic cancer prevention on Newsmax.) Now, a newly published clinical research study suggests that aspirin, which has also been shown to reduce the risk of colorectal cancer, may also significantly reduce the risk of developing pancreatic cancer.

This new research study appears in the journal Cancer Prevention Research. This clinical research study was performed at the Mayo Clinic, and included 904 patients recently diagnosed with pancreatic cancer and 1,224 healthy age-matched and gender-matched “control” patients. In this case-control study, the impact of aspirin intake was analyzed in both groups of patients.

In this study, the use of aspirin at least one day per month was associated with a very significant 26 percent reduction in the risk of developing pancreatic cancer. Among patients who took low-dose aspirin (81 mg per day) every day for heart disease prevention, the risk of pancreatic cancer was reduced by 33 percent.

The findings of this important study suggest that the humble aspirin tablet may significantly reduce the risk of developing what is arguably the most lethal of all cancers (in addition to reducing the risk of colorectal cancer and, potentially, other cancers as well). As I discuss in A Cancer Prevention Guide for the Human Race, even a relatively modest reduction in the risk of the deadliest types of cancer can be an important achievement, because our therapies for these kinds of cancer, including pancreatic cancer, so rarely result in a cure. While this case-control study is not as statistically powerful as a prospective, randomized, placebo-controlled clinical research study, prior laboratory and clinical research studies have also shown that aspirin can reduce pancreatic cancer cell growth. The findings of these previous studies, therefore, generally support the findings of this new Mayo Clinic study suggesting that aspirin may, indeed, reduce the risk of developing pancreatic cancer.

I must caution readers that aspirin, like all medications, can be associated with significant side effects. In the case of aspirin, specifically, GI tract irritation can cause abdominal pain, nausea, vomiting, and even GI tract bleeding. Aspirin can also increase the risk of bleeding in other areas of the body, and can be toxic to the kidneys in some patients as well. Therefore, if you are considering the addition of low-dose aspirin to your cancer prevention lifestyle, you should first check with your personal physician to ensure that it is safe for you to do so.

For a comprehensive guide to living an evidence-based cancer prevention lifestyle, order your copy of my new book, A Cancer Prevention Guide for the Human Race.  For the price of a cheeseburger, fries, and a shake, you can purchase this landmark new book, in both paperback and e-book formats, and begin living an evidence-based cancer prevention lifestyle today!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

The blood pressure medication clonidine and the antidepressant venlafaxine (Effexor) both reduce hot flashes caused by breast cancer treatment and by menopause.

CLONIDINE AND THE ANTIDEPRESSANT EFFEXOR BOTH REDUCE HOT FLASHES

The modern management of breast cancer often includes “hormonal therapy,” in which medications that block the effects of estrogen, or decrease the amount of estrogen manufactured by the body, are used to reduce the risk of breast cancer recurrence.  Despite significantly lowering the risk of breast cancer recurrence in patients with estrogen-sensitive breast tumors, recent clinical research studies have shown that fewer than one-half of all breast cancer patients actually go on to complete the recommended 5-year course of hormonal therapy.  (This very poor level of compliance with a medical therapy proven to lower recurrence and death rates associated with breast cancer is particularly an issue among younger women.)

While there are several reasons why more than half of all breast cancer patients do not complete their recommended course of hormonal therapy, one of the major causes, and especially among younger patients, is that these medications are commonly associated with significant side effects, including the same hot flashes that frequently accompany menopause.

Numerous treatment interventions have been tried in an effort prevent hot flashes associated with breast cancer therapy (as well as hot flashes in postmenopausal women without breast cancer), but very few of these therapies have been shown to have any clinically significant benefit. However, several previous clinical studies have suggested that certain types of antidepressant medications, as well as the blood pressure medication clonidine, may reduce the severity and frequency of hot flashes. Unfortunately, much of the research in this area has been of rather low quality, and so the findings of these lower level studies have not radically changed the way that most physicians have managed their patients’ hot flashes. Now, a newly published prospective, randomized, placebo-controlled, blinded clinical research study, which appears in the current issue of the Journal of Clinical Oncology, strongly suggests that venlafaxine (also known by its trade name, Effexor®), a medication that is part of the new “serotonin–norepinephrine reuptake inhibitors” (SNRIs) class of antidepressants, and clonidine may both be effective in decreasing the severity and frequency of hot flashes in women with a history of breast cancer.

In this study, 102 women with a history of both breast cancer and severe hot flashes were secretly and randomly assigned to take either venlafaxine (75 mg per day), clonidine (0.1 mg per day), or an identical-appearing placebo (sugar) pill. Following 12 weeks of observation, 80 patients remained in this clinical study. At the end of this 12-week clinical study, both clonidine and venlafaxine were found to significantly decrease the severity and frequency of hot flashes, when compared to placebo pills. Although both medications were clinically effective in reducing hot flashes, and although venlafaxine resulted in a more rapid reduction in hot flashes than clonidine, clonidine was associated with a greater overall improvement in hot flashes, when compared to venlafaxine, after 12 weeks of treatment. (Venlafaxine was also associated with a greater incidence of nausea, constipation, and appetite loss, compared to clonidine.)

The findings of this study add to those of prior studies that have shown a 15 to 25% reduction in the severity and frequency of hot flashes with antidepressants such as venlafaxine, and with clonidine. Moreover, prior studies have shown that these two medications reduce the severity and frequency of hot flashes in women with a history of breast cancer as well as in postmenopausal women without a prior history of breast cancer.

One important limitation of this study is its small size, and its high patient drop-out rate, which resulted in small numbers of patient volunteers in each of the three “arms” of this prospective, randomized, blinded, placebo-controlled study.  However, the findings of this small clinical research study, nonetheless, are still consistent with those of previously published studies; and taken together, these studies suggest that venlafaxine (and other modern antidepressant medications) and clonidine may be effective in reducing the severity and frequency of hot flashes in both breast cancer patients who are undergoing hormonal therapy for their cancer and in postmenopausal women with menopause-associated hot flashes.

For a comprehensive guide to living an evidence-based cancer prevention lifestyle, order your copy of my new book, A Cancer Prevention Guide for the Human Race.  For the price of a cheeseburger, fries, and a shake, you can purchase this landmark new book, in both paperback and e-book formats, and begin living an evidence-based cancer prevention lifestyle today!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam

Welcome to Weekly Health Update

New research suggests that moderate chocolate consumption can significantly decrease the risk of heart disease, stroke, and diabetes.

NEW RESEARCH SAYS THAT CHOCOLATE DECREASES CARDIOVASCULAR DISEASE RISK AND DIABETES

Cocoa, from which chocolate is made, is known to be rich in flavonol antioxidants, as well as other compounds that appear to reduce the risk of developing the cholesterol plaques that cause coronary artery disease, stroke, and peripheral vascular disease. Cocoa has also been shown to improve the function and health of critical blood vessels in the body, which can lower elevated blood pressure. Moreover, additional research has shown that cocoa may also decrease the risk of diabetes.

Milk chocolate contains considerably more fat and sugar than dark chocolate, and these milk chocolate additives are well known to increase the risk of obesity, diabetes, and cardiovascular disease. Therefore, dark chocolate has been more often recommended than milk chocolate as a possibly healthy treat. However, several public health studies have suggested that even milk chocolate may still possess clinically significant cardiovascular health benefits, despite its high fat and high sugar content.

A newly published meta-analysis study, which appears in the British Medical Journal, adds weight to the possibility that even milk chocolate might have heart-healthy properties. In this meta-analysis study, seven previously published public health research studies, which included 114,009 research volunteers, were analyzed. This analysis revealed that 5 of these 7 previously published public health studies found that increased chocolate consumption was associated with a significant decrease in the risk of cardiovascular disease and diabetes. Specifically, research volunteers who reported the highest levels of chocolate consumption were observed to be 37 percent less likely to develop heart disease, 31 percent less likely to develop diabetes, and 29 percent less likely to have a stroke when compared to the volunteers who reported the least chocolate consumption.

Now, for the (possibly) bad news….  None of these seven public health research studies were randomized clinical research studies.  All were so-called “observational” studies, wherein groups of volunteers completed questionnaires regarding their diet and lifestyle habits, and were then observed over time for the development of new health problems.  The obvious weakness of observational studies, in general, is their reliance upon the often inaccurate self-reporting by research volunteers on questionnaires designed to assess their dietary and lifestyle habits.  The other weakness of these particular research studies is that they did not identify which types of chocolate were associated either with the least or the greatest health benefits (nor is it clear from these studies whether or not there is an optimal amount of chocolate intake necessary to produce the greatest possible health benefits).  All of these important disclaimers aside, multiple clinical research studies have previously shown very significant potential health benefits associated with regular chocolate consumption.  At the same time, in view of the clear association of increased fat and sugar intake with obesity, diabetes, high blood pressure, and cardiovascular disease risk, among other health problems, my recommendation to my patients and readers is to take moderate amounts of dark chocolate, and other lower-fat and lower-sugar chocolates, as part of a heart-healthy lifestyle!

For a comprehensive guide to living an evidence-based cancer prevention lifestyle, order your copy of my new book, A Cancer Prevention Guide for the Human Race.  For the price of a cheeseburger, fries, and a shake, you can purchase this landmark new book, in both paperback and e-book formats, and begin living an evidence-based cancer prevention lifestyle today!

For a groundbreaking overview of cancer risks, and evidence-based strategies to reduce your risk of developing cancer, order your copy of my new book, “A Cancer Prevention Guide for the Human Race,” from Amazon, Barnes & Noble, Books-A-Million,Vroman’s Bookstore, and other fine bookstores!

On Thanksgiving Day, 2010, A Cancer Prevention Guide for the Human Race was ranked #6 among all cancer-related books on the Amazon.com “Top 100 Bestseller’s List” for Kindle e-books! On Christmas Day, 2010, A Cancer Prevention Guide for the Human Race was the #1 book on the Amazon.com “Top 100 New Book Releases in Cancer” list!

Disclaimer:  As always, my advice to readers is to seek the advice of your physician before making any significant changes in medications, diet, or level of physical activity

Dr. Wascher is an oncologic surgeon, professor of surgery, cancer researcher, oncology consultant, and a widely published author

For a different perspective on Dr. Wascher, please click on the following YouTube link:

Texas Blues Jam